Pfizer agrees to let other companies make its COVID-19 pill

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 99%

Business News News

Business Business Latest News,Business Business Headlines

Drugmaker Pfizer Inc. has signed a deal with a UN-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.

issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world's population.

He estimated that other drugmakers would be able to start producing the pill within months, but acknowledged the agreement wouldn't please everyone. Earlier this month, Pfizer said its pill cut the risk of hospitalization and death by nearly 90% in people with mild to moderate coronavirus infections. Independent experts recommended halting the company's study based on its promising results.

Britain authorized Merck's COVID-19 pill earlier this month, and it is pending approval elsewhere. In a similar deal with the Medicines Patent Pool announced in October, Merck agreed to let other drugmakers make its COVID-19 pill, molnupiravir, available in 105 poorer countries.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Same with the vaccines

Finally. This will save lives

Heard shocking story not known if true but costs $17.00 to produce and bills customers in $700.00? Let’s get facts to us THANKS

Don't want it? Don't take it. No one cares.

Key word “experimental” COVID-19 pill. 🤑

Pfizer is such a corrupt and evil company!

So we can get it at McDonald’s?

lol.. for free?

I wonder why they didn't come up with a pill before the vaccine.....

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in BUSİNESS

Business Business Latest News, Business Business Headlines